158 related articles for article (PubMed ID: 31022440)
1. Topical nanostructured lipid carriers/inorganic sunscreen combination for alleviation of all-trans retinoic acid-induced photosensitivity: Box-Behnken design optimization, in vitro and in vivo evaluation.
Asfour MH; Kassem AA; Salama A
Eur J Pharm Sci; 2019 Jun; 134():219-232. PubMed ID: 31022440
[TBL] [Abstract][Full Text] [Related]
2. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design.
Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD
Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618
[TBL] [Abstract][Full Text] [Related]
3. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
4. Bemotrizinol-Loaded Carnauba Wax-Based Nanostructured Lipid Carriers for Sunscreen: Optimization, Characterization, and In vitro Evaluation.
Medeiros TS; Moreira LMCC; Oliveira TMT; Melo DF; Azevedo EP; Gadelha AEG; Fook MVL; Oshiro-Júnior JA; Damasceno BPGL
AAPS PharmSciTech; 2020 Oct; 21(8):288. PubMed ID: 33073311
[TBL] [Abstract][Full Text] [Related]
5. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
6. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
8. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approach.
Moghddam SM; Ahad A; Aqil M; Imam SS; Sultana Y
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):617-624. PubMed ID: 27050533
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Salicylic Acid Loaded Nanostructured Lipid Carriers Using Box-Behnken Design: Optimization, Characterization and Physicochemical Stability.
Pantub K; Wongtrakul P; Janwitayanuchit W
J Oleo Sci; 2017; 66(12):1311-1319. PubMed ID: 29199206
[TBL] [Abstract][Full Text] [Related]
10. Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters.
Nikolić S; Keck CM; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):276-84. PubMed ID: 21600969
[TBL] [Abstract][Full Text] [Related]
11. Design and Optimization of Cationic Nanocapsules for Topical Delivery of Tretinoin: Application of the Box-Behnken Design,
Ebrahimi S; Mahjub R; Haddadi R; Vafaei SY
Biomed Res Int; 2021; 2021():4603545. PubMed ID: 34934769
[TBL] [Abstract][Full Text] [Related]
12. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
Kovačević AB; Müller RH; Keck CM
Int J Pharm; 2020 Feb; 576():118918. PubMed ID: 31870954
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies.
Puglia C; Damiani E; Offerta A; Rizza L; Tirendi GG; Tarico MS; Curreri S; Bonina F; Perrotta RE
Eur J Pharm Sci; 2014 Jan; 51():211-7. PubMed ID: 24157543
[TBL] [Abstract][Full Text] [Related]
15. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies.
Jazuli I; Annu ; Nabi B; Moolakkadath T; Alam T; Baboota S; Ali J
J Pharm Sci; 2019 Sep; 108(9):3082-3090. PubMed ID: 31077685
[TBL] [Abstract][Full Text] [Related]
16. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
[TBL] [Abstract][Full Text] [Related]
17. A logical approach to optimize the nanostructured lipid carrier system of irinotecan: efficient hybrid design methodology.
Negi LM; Jaggi M; Talegaonkar S
Nanotechnology; 2013 Jan; 24(1):015104. PubMed ID: 23221112
[TBL] [Abstract][Full Text] [Related]
18. Self-Emulsifying Drug Delivery System of Simvastatin: Formulation Development, Optimization by Box- Behnken Design,
Verma M; Nanda A; Kumar Y
Recent Pat Drug Deliv Formul; 2018; 12(3):199-211. PubMed ID: 30345934
[TBL] [Abstract][Full Text] [Related]
19. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
Jojo GM; Kuppusamy G; De A; Karri VVSNR
Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
[TBL] [Abstract][Full Text] [Related]
20. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
Rizwanullah M; Amin S; Ahmad J
J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
